2020 annual financial data
Aligos Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was 704.05%.
Operating income was -97,834,000 USD and net income was -108,543,000 USD.
Operating cash flow was -74,263,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -10,548,000 USD
- Operating income
- -97,834,000 USD
- Net income
- -108,543,000 USD
- Operating cash flow
- -74,263,000 USD